Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels

Aylin Yildirir, Funda Aybar, Lale Tokgozoglu, Hakan Yarali, Giray Kabakci, Orhan Bukulmez, Incilay Sinici, Ali Oto

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

In order to investigate the effect of hormone replacement therapy (HRT) on plasma homocysteine and C-reactive protein (CRP) levels 46 healthy postmenopausal women were prospectively enrolled. HRT, which was either 0.625 mg/day conjugated equine estrogen (CEE) plus 2.5 mg/day medroxyprogesterone acetate (MPA) or 0.625 mg/day CEE alone were administered. After 6 months, estrogen alone significantly increased serum CRP concentrations (p =0.039), however, estrogen plus progesterone therapy did not significantly alter serum CRP levels. Both regimens significantly decreased plasma homocysteine levels (CEE group p =0.034, CEE +MPA group p =0.007). It was concluded that the reduction in plasma homocysteine levels with both regimens might contribute to the cardiovascular benefit of HRT and the CRP raising effect of estrogen might be partially prevented by the addition of progesterone.

Original languageEnglish (US)
Pages (from-to)54-58
Number of pages5
JournalGynecologic and Obstetric Investigation
Volume53
Issue number1
DOIs
StatePublished - 2002

Fingerprint

Conjugated (USP) Estrogens
Hormone Replacement Therapy
Homocysteine
C-Reactive Protein
Medroxyprogesterone Acetate
Estrogens
Progesterone
Blood Proteins
Therapeutics

Keywords

  • C-reactive protein
  • Homocysteine
  • Hormone replacement therapy
  • Menopause

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels. / Yildirir, Aylin; Aybar, Funda; Tokgozoglu, Lale; Yarali, Hakan; Kabakci, Giray; Bukulmez, Orhan; Sinici, Incilay; Oto, Ali.

In: Gynecologic and Obstetric Investigation, Vol. 53, No. 1, 2002, p. 54-58.

Research output: Contribution to journalArticle

Yildirir, A, Aybar, F, Tokgozoglu, L, Yarali, H, Kabakci, G, Bukulmez, O, Sinici, I & Oto, A 2002, 'Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels', Gynecologic and Obstetric Investigation, vol. 53, no. 1, pp. 54-58. https://doi.org/10.1159/000049412
Yildirir, Aylin ; Aybar, Funda ; Tokgozoglu, Lale ; Yarali, Hakan ; Kabakci, Giray ; Bukulmez, Orhan ; Sinici, Incilay ; Oto, Ali. / Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels. In: Gynecologic and Obstetric Investigation. 2002 ; Vol. 53, No. 1. pp. 54-58.
@article{b72a40f0e3ba45eb9353ad4d117478b6,
title = "Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels",
abstract = "In order to investigate the effect of hormone replacement therapy (HRT) on plasma homocysteine and C-reactive protein (CRP) levels 46 healthy postmenopausal women were prospectively enrolled. HRT, which was either 0.625 mg/day conjugated equine estrogen (CEE) plus 2.5 mg/day medroxyprogesterone acetate (MPA) or 0.625 mg/day CEE alone were administered. After 6 months, estrogen alone significantly increased serum CRP concentrations (p =0.039), however, estrogen plus progesterone therapy did not significantly alter serum CRP levels. Both regimens significantly decreased plasma homocysteine levels (CEE group p =0.034, CEE +MPA group p =0.007). It was concluded that the reduction in plasma homocysteine levels with both regimens might contribute to the cardiovascular benefit of HRT and the CRP raising effect of estrogen might be partially prevented by the addition of progesterone.",
keywords = "C-reactive protein, Homocysteine, Hormone replacement therapy, Menopause",
author = "Aylin Yildirir and Funda Aybar and Lale Tokgozoglu and Hakan Yarali and Giray Kabakci and Orhan Bukulmez and Incilay Sinici and Ali Oto",
year = "2002",
doi = "10.1159/000049412",
language = "English (US)",
volume = "53",
pages = "54--58",
journal = "Gynecologic and Obstetric Investigation",
issn = "0378-7346",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels

AU - Yildirir, Aylin

AU - Aybar, Funda

AU - Tokgozoglu, Lale

AU - Yarali, Hakan

AU - Kabakci, Giray

AU - Bukulmez, Orhan

AU - Sinici, Incilay

AU - Oto, Ali

PY - 2002

Y1 - 2002

N2 - In order to investigate the effect of hormone replacement therapy (HRT) on plasma homocysteine and C-reactive protein (CRP) levels 46 healthy postmenopausal women were prospectively enrolled. HRT, which was either 0.625 mg/day conjugated equine estrogen (CEE) plus 2.5 mg/day medroxyprogesterone acetate (MPA) or 0.625 mg/day CEE alone were administered. After 6 months, estrogen alone significantly increased serum CRP concentrations (p =0.039), however, estrogen plus progesterone therapy did not significantly alter serum CRP levels. Both regimens significantly decreased plasma homocysteine levels (CEE group p =0.034, CEE +MPA group p =0.007). It was concluded that the reduction in plasma homocysteine levels with both regimens might contribute to the cardiovascular benefit of HRT and the CRP raising effect of estrogen might be partially prevented by the addition of progesterone.

AB - In order to investigate the effect of hormone replacement therapy (HRT) on plasma homocysteine and C-reactive protein (CRP) levels 46 healthy postmenopausal women were prospectively enrolled. HRT, which was either 0.625 mg/day conjugated equine estrogen (CEE) plus 2.5 mg/day medroxyprogesterone acetate (MPA) or 0.625 mg/day CEE alone were administered. After 6 months, estrogen alone significantly increased serum CRP concentrations (p =0.039), however, estrogen plus progesterone therapy did not significantly alter serum CRP levels. Both regimens significantly decreased plasma homocysteine levels (CEE group p =0.034, CEE +MPA group p =0.007). It was concluded that the reduction in plasma homocysteine levels with both regimens might contribute to the cardiovascular benefit of HRT and the CRP raising effect of estrogen might be partially prevented by the addition of progesterone.

KW - C-reactive protein

KW - Homocysteine

KW - Hormone replacement therapy

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=0036152779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036152779&partnerID=8YFLogxK

U2 - 10.1159/000049412

DO - 10.1159/000049412

M3 - Article

C2 - 11803230

AN - SCOPUS:0036152779

VL - 53

SP - 54

EP - 58

JO - Gynecologic and Obstetric Investigation

JF - Gynecologic and Obstetric Investigation

SN - 0378-7346

IS - 1

ER -